Navigation Links
Regeneron to Report Fourth Quarter and Full Year 2012 Financial and Operating Results and Host Conference Call and Webcast on February 14, 2013
Date:1/28/2013

TARRYTOWN, N.Y., Jan. 28, 2013 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its fourth quarter and full year 2012 financial and operating results on Thursday, February 14, 2013, before the U.S. financial markets open.  The Company will host a conference call and simultaneous webcast at 8:30 AM EST that day.

Conference Call InformationTo access this call, dial (888) 660-6127 (U.S.) or (973) 890-8355 (International).  A link to the webcast may be accessed from the 'Events and Presentations' page of Regeneron's website at www.regeneron.com.  A replay of the conference call and webcast will be archived on the Company's website and will be available for 30 days. 

About Regeneron Pharmaceuticals, Inc.Regeneron is a leading science-based biopharmaceutical company based in Tarrytown, New York that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.  Regeneron markets medicines for eye diseases, colorectal cancer, and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including hypercholesterolemia, rheumatoid arthritis, and asthma.  For additional information about the company, please visit www.regeneron.com.Contact Information:Michael Aberman, M.D.

Peter DworkinInvestor Relations

Corporate Communications914-847-7799

914.847.764michael.aberman@regeneron.com

peter.dworkin@regeneron.com 


'/>"/>
SOURCE Regeneron Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Regeneron and Bayer Announce Co-Promotion Agreement With Santen For EYLEA® (aflibercept) Injection in Japan
2. Regeneron Provides Update On FDA Advisory Committee Discussion of ARCALYST® (rilonacept) Injection
3. Regeneron Announces June 2012 Investor Conference Presentations
4. Regeneron to Report Second Quarter 2012 Financial and Operating Results and Host Conference Call and Webcast on July 25, 2012
5. Regeneron Announces September 2012 Investor Conference Presentations
6. Regeneron Named Worlds #1 Biopharmaceutical Employer in Science Magazine Annual Survey
7. BioMed Realty Announces 80,500 Square Foot Lease Expansion For Regeneron Pharmaceuticals
8. Sanofi and Regeneron Announce Publication of Phase 2 Results with LDL Cholesterol-Lowering PCSK9 Antibody in the New England Journal of Medicine
9. Sanofi and Regeneron Announce Patient Enrollment in Cardiovascular Outcomes Trial with Antibody to PCSK9 for Hypercholesterolemia
10. Regeneron Announces Presentation at the Deutsche Bank 2012 dbAccess BioFEST
11. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... 2, 2015 Thync today launched the ... in minutes; feeling more calm or energized when you need ... sleek and simple wearable is placed on the head and ... The neurosignaling device is operated with an accompanying app to ... your energy level. "Our mission at Thync ...
(Date:6/2/2015)... et MADRID , ... Présentation orale (extrait 10503) effectuée lors de la ...    PharmaMar communique que Janssen Research ... données de l,étude multicentrique de phase III SAR3007 ... sans progression (PFS) avec la trabectédine (YONDELIS ® ...
(Date:6/1/2015)... /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CSE: ... on Omega-3 therapies for cardiovascular disease (CVD) and ... results for the three months ended March 31, ... Canadian dollars unless otherwise stated. "Pivotal ... its limited financial resources," stated Mr. Eugenio ...
Breaking Medicine Technology:Thync Launches First Wearable to Shift Your State of Mind 2Thync Launches First Wearable to Shift Your State of Mind 3Thync Launches First Wearable to Shift Your State of Mind 4PharmaMar annonce que l'étude Janssen montre que la Trabectédine améliore la lutte contre la maladie chez les patients atteints du sarcome des tissus mous à un stade avancé 2PharmaMar annonce que l'étude Janssen montre que la Trabectédine améliore la lutte contre la maladie chez les patients atteints du sarcome des tissus mous à un stade avancé 3PharmaMar annonce que l'étude Janssen montre que la Trabectédine améliore la lutte contre la maladie chez les patients atteints du sarcome des tissus mous à un stade avancé 4PharmaMar annonce que l'étude Janssen montre que la Trabectédine améliore la lutte contre la maladie chez les patients atteints du sarcome des tissus mous à un stade avancé 5PharmaMar annonce que l'étude Janssen montre que la Trabectédine améliore la lutte contre la maladie chez les patients atteints du sarcome des tissus mous à un stade avancé 6Pivotal Therapeutics Announces First Quarter Financial Results 2Pivotal Therapeutics Announces First Quarter Financial Results 3Pivotal Therapeutics Announces First Quarter Financial Results 4Pivotal Therapeutics Announces First Quarter Financial Results 5
... Omron Healthcare, Inc., the number one brand recommended by ... donation of 300 blood pressure monitors worth more than $30,000 ... be used by ASH to provide free blood pressure screenings ... Island and northern New Jersey. "High blood pressure ...
... 20, 2011 Olympus Corporation of the Americas (OCA) ... Executive Officer, will retire from the company effective May ... Chief Financial Officer, will be promoted to President – ... to Michael C. Woodford, Olympus Corporation President and Chief ...
Cached Medicine Technology:Omron Healthcare Announces Donation to the American Society of Hypertension, Inc. 2Gumz to Retire as President and CEO of Olympus Corporation of the Americas 2
(Date:6/2/2015)... June 02, 2015 Amercanex, the ... Jim Miller to become Amercanex’s new Chief Technology ... marketplace in which cultivators, wholesale distributors and retail ... in a fully transparent intra-state market. , Jim ... the financial technology space, helping innovative technology companies ...
(Date:6/2/2015)... Date: Thursday, June 4, 2015 , Time: 2 ... Broad Street, 4th floor, Philadelphia, Pa 19107 , ... will visit Philadelphia City Council to urge city leaders ... C in Philadelphia’s at-risk populations. , Foundation leaders and ... B United Philadelphia (HBUP), will join Hepatitis C Allies ...
(Date:6/2/2015)... 02, 2015 SB 277 (CA Legislature, ... children to attend public or private school. SB277 cleared ... bypassed the Appropriations Committee (Sacramento Bee, May 11, 2015, ... hearings. , “We believe that this bill affects ... more than it will (the) affect public health of ...
(Date:6/1/2015)... City, NY (PRWEB) June 02, 2015 ... honors Lynn Lester as a 2015-2016 inductee ... is recognized with this prestigious distinction for leadership in ... for professional women, boasting more than 700,000 members and ... honor Lynn Lester with this prestigious award,” said NAPW ...
(Date:6/1/2015)... 2015 The National Association of ... 2015-2016 inductee into its VIP Woman of the ... distinction for leadership in business. NAPW is the ... boasting more than 700,000 members and over 200 ... Kathy into this exceptional group of professional women,” ...
Breaking Medicine News(10 mins):Health News:Amercanex Names Jim Miller to CTO Position 2Health News:Hepatitis B Foundation to Urge Philadelphia Leaders to Make Viral Hepatitis Prevention a Local Priority 2Health News:A Voice For Choice Releases A Statement As SB277 Is Referred To Single Assembly Committee And Bypasses Education and Judicial Scrutiny 2Health News:National Association of Professional Women Inducts Lynn Lester, Director of Clinical Operations/CEO, Recovery Treatment Center, Into its VIP Woman of the Year Circle 2Health News:The National Association of Professional Women Inducts Kathy Everette-Gaines, Community Relations Coordinator, Into its VIP Professional Woman of the Year Circle 2
... Heavy drinkers and heavy,smokers develop Alzheimer,s disease years ... or smoke heavily, according to research that,will be ... Anniversary,Annual Meeting in Chicago, April 12-19, 2008., ... if we can,reduce or eliminate heavy smoking and ...
... April 17 CTG (Nasdaq: CTGX ),an international ... it would release its 2008 first quarter,financial results on ... hold a conference call to discuss its financial results ... a.m. Eastern Time. CTG,Chairman and Chief Executive Officer James ...
... Calif., April 17 The National Center for,Autism ... for autism research, education and family support,services has ... are,flocking to NCARE resulting from the announcement to ... that families desperately need centralized,autism resources., Soonhee ...
... Seeking Nominations for 2008 Awards to Celebrate Exemplary ... CHICAGO, April 17 Last summer, when Sally Lemke ... in the city,s,Austin community, she still felt like a ... her layoff, she was recognized for her commitment and,passion ...
... PITTSBURGH, April 17 MSA (NYSE: MSA ), ... sophisticated,products that protect people,s health and safety, announced today ... call live via the,Internet on Thursday, May 1, 2008 ... minutes., Investors and interested parties will have the ...
... Seven children,from across the United States are gaining ... for patients,with spina bifida. The surgeries were conducted ... The children previously required the insertion of ... incontinence. But as a result of the,surgery, they ...
Cached Medicine News:Health News:Alzheimer's Starts Earlier for Heavy Drinkers, Smokers 2Health News:CTG Announces 2008 First Quarter Conference Call and Webcast Information 2Health News:California's First Non-profit Center for Autism Research, Education and Family Services 2Health News:Chicagoland Super Star Community and Public Health Nurses - Now Is Your Chance to Win $25,000 2Health News:Chicagoland Super Star Community and Public Health Nurses - Now Is Your Chance to Win $25,000 3Health News:MSA Schedules First Quarter Earnings Webcast 2Health News:Beaumont Sees Results in Nation's 1st Urinary Nerve Rewiring Surgeries for Spina Bifida Patients 2Health News:Beaumont Sees Results in Nation's 1st Urinary Nerve Rewiring Surgeries for Spina Bifida Patients 3
... The Monarc Subfascial Hammock™ is ... female patients suffering from stress urinary ... by supporting the urethra during abdominal ... or laughing. Monarc's outside-to-in transobturator approach ...
... innovative architecture of the Uretex® ... and integrity for tension-free sling ... anchors securely to surrounding tissue ... alternate fixation devices, minimizing risk ...
Meets the demanding requirements of most pelvic floor reconstructive procedures, and is highly resistant to suture pull-through, demonstrating long-term durability, and serves as a structural support...
NephroMax High Pressure Nephrostomy Balloon Catheter allows one-step, atraumatic dilatation of the nephrostomy tract....
Medicine Products: